| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 9.31e-06 | 343 | 61 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.63e-05 | 129 | 61 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 7.42e-05 | 459 | 61 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 8.13e-05 | 465 | 61 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 9.79e-05 | 151 | 61 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.13e-04 | 627 | 61 | 9 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.74e-04 | 664 | 61 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | channel activity | 1.87e-04 | 525 | 61 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.90e-04 | 526 | 61 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 4.61e-04 | 758 | 61 | 9 | GO:0015318 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.36e-04 | 334 | 61 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 6.39e-04 | 793 | 61 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 8.86e-04 | 140 | 61 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.36e-03 | 18 | 61 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.42e-03 | 184 | 61 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | phosphatidic acid binding | 2.43e-03 | 24 | 61 | 2 | GO:0070300 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.87e-03 | 193 | 61 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.09e-03 | 197 | 61 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | NAD+-protein poly-ADP-ribosyltransferase activity | 3.30e-03 | 28 | 61 | 2 | GO:0003950 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 3.76e-03 | 102 | 61 | 3 | GO:0005249 | |
| GeneOntologyMolecularFunction | NAD+-protein ADP-ribosyltransferase activity | 3.78e-03 | 30 | 61 | 2 | GO:1990404 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.03e-03 | 31 | 61 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 4.56e-03 | 33 | 61 | 2 | GO:0005217 | |
| GeneOntologyBiologicalProcess | activation of cysteine-type endopeptidase activity | 1.09e-05 | 15 | 61 | 3 | GO:0097202 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.13e-04 | 378 | 61 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | lamellipodium | 5.56e-04 | 230 | 61 | 5 | GO:0030027 | |
| GeneOntologyCellularComponent | cell leading edge | 6.14e-04 | 500 | 61 | 7 | GO:0031252 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 8.00e-04 | 523 | 61 | 7 | GO:1902495 | |
| GeneOntologyCellularComponent | site of polarized growth | 8.55e-04 | 253 | 61 | 5 | GO:0030427 | |
| GeneOntologyCellularComponent | transporter complex | 1.07e-03 | 550 | 61 | 7 | GO:1990351 | |
| Domain | K_chnl_volt-dep_ELK | 3.04e-05 | 3 | 60 | 2 | IPR003950 | |
| Domain | Ion_trans_dom | 3.24e-05 | 114 | 60 | 5 | IPR005821 | |
| Domain | Ion_trans | 3.24e-05 | 114 | 60 | 5 | PF00520 | |
| Domain | PAS_9 | 4.49e-04 | 10 | 60 | 2 | PF13426 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 9.01e-04 | 14 | 60 | 2 | IPR003938 | |
| Domain | - | 1.18e-03 | 16 | 60 | 2 | 1.10.506.10 | |
| Domain | RasGAP_dom | 1.50e-03 | 18 | 60 | 2 | IPR001936 | |
| Domain | PAS_fold_3 | 2.46e-03 | 23 | 60 | 2 | IPR013655 | |
| Domain | PAS_3 | 2.46e-03 | 23 | 60 | 2 | PF08447 | |
| Domain | PAS-assoc_C | 2.68e-03 | 24 | 60 | 2 | IPR000700 | |
| Domain | PAC | 3.14e-03 | 26 | 60 | 2 | IPR001610 | |
| Domain | PAC | 3.14e-03 | 26 | 60 | 2 | SM00086 | |
| Domain | PAC | 3.14e-03 | 26 | 60 | 2 | PS50113 | |
| Domain | - | 3.67e-03 | 321 | 60 | 5 | 3.80.10.10 | |
| Domain | L_dom-like | 4.02e-03 | 328 | 60 | 5 | IPR032675 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 36596388 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 31269804 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 35650472 | ||
| Pubmed | SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. | 3.13e-06 | 2 | 62 | 2 | 24344202 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 33857259 | ||
| Pubmed | Distribution and functional properties of human KCNH8 (Elk1) potassium channels. | 9.37e-06 | 3 | 62 | 2 | 12890647 | |
| Pubmed | Interaction with Sug1 enables Ipaf ubiquitination leading to caspase 8 activation and cell death. | 9.37e-06 | 3 | 62 | 2 | 20085538 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 22028615 | ||
| Pubmed | IQGAP1 stimulates actin assembly through the N-WASP-Arp2/3 pathway. | 1.87e-05 | 4 | 62 | 2 | 17085436 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 27974463 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 24123685 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 15181153 | ||
| Pubmed | ASC- and caspase-8-dependent apoptotic pathway diverges from the NLRC4 inflammasome in macrophages. | 3.12e-05 | 5 | 62 | 2 | 29491424 | |
| Pubmed | ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. | 3.12e-05 | 5 | 62 | 2 | 12646168 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 24078693 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 34880332 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 31251782 | ||
| Pubmed | Fas-mediated inflammatory response in Listeria monocytogenes infection. | 6.53e-05 | 7 | 62 | 2 | 23509366 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 28410991 | ||
| Pubmed | ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation. | 8.69e-05 | 8 | 62 | 2 | 30563862 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 29262324 | ||
| Pubmed | An Apoptotic Caspase Network Safeguards Cell Death Induction in Pyroptotic Macrophages. | 1.12e-04 | 9 | 62 | 2 | 32726624 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 1.37e-04 | 442 | 62 | 6 | 15815621 | |
| Pubmed | Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate. | 1.39e-04 | 10 | 62 | 2 | 26503718 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.43e-04 | 1105 | 62 | 9 | 35748872 | |
| Pubmed | Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense. | 1.70e-04 | 11 | 62 | 2 | 32298652 | |
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 25959047 | ||
| Pubmed | A pathway sensor for genome-wide screens of intracellular proteolytic cleavage. | 2.04e-04 | 12 | 62 | 2 | 18387192 | |
| Pubmed | 2.16e-04 | 1168 | 62 | 9 | 19946888 | ||
| Pubmed | ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. | 2.41e-04 | 13 | 62 | 2 | 34686350 | |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 32763970 | ||
| Pubmed | A Genome-wide CRISPR Death Screen Identifies Genes Essential for Oxidative Phosphorylation. | 2.41e-04 | 13 | 62 | 2 | 27667664 | |
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 25704009 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 2.68e-04 | 1203 | 62 | 9 | 29180619 | |
| Pubmed | Noncanonical inflammasome activation by intracellular LPS independent of TLR4. | 2.81e-04 | 14 | 62 | 2 | 23887873 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.73e-04 | 202 | 62 | 4 | 33005030 | |
| Pubmed | Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. | 5.24e-04 | 19 | 62 | 2 | 19641492 | |
| Pubmed | 5.82e-04 | 20 | 62 | 2 | 12743021 | ||
| Pubmed | Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis. | 7.72e-04 | 23 | 62 | 2 | 32597834 | |
| Pubmed | 8.41e-04 | 24 | 62 | 2 | 30348676 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 9.09e-04 | 1425 | 62 | 9 | 30948266 | |
| Pubmed | 9.14e-04 | 25 | 62 | 2 | 27917412 | ||
| Pubmed | 9.14e-04 | 25 | 62 | 2 | 38588611 | ||
| Pubmed | Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. | 9.89e-04 | 26 | 62 | 2 | 23770605 | |
| Pubmed | 1.08e-03 | 653 | 62 | 6 | 22586326 | ||
| Pubmed | 1.13e-03 | 255 | 62 | 4 | 15324660 | ||
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | 1.28e-03 | 926 | 62 | 7 | 20877624 | |
| Pubmed | 1.59e-03 | 33 | 62 | 2 | 19834762 | ||
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 1.69e-03 | 34 | 62 | 2 | 16498405 | |
| Pubmed | 1.70e-03 | 285 | 62 | 4 | 21423176 | ||
| Cytoband | 2q33.3 | 7.62e-04 | 30 | 62 | 2 | 2q33.3 | |
| Cytoband | 4p14 | 1.49e-03 | 42 | 62 | 2 | 4p14 | |
| Cytoband | 22q13.31 | 1.79e-03 | 46 | 62 | 2 | 22q13.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q33 | 2.73e-03 | 205 | 62 | 3 | chr2q33 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 160 | 62 | 5 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-06 | 167 | 62 | 5 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 3.95e-06 | 170 | 62 | 5 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.14e-06 | 192 | 62 | 5 | faead5875a54fe8f1848ae36008aae4c0f7cb1c7 | |
| ToppCell | proximal-3-Hematologic-Plasmacytoid_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.14e-06 | 192 | 62 | 5 | 86938c7d2bb1a7afb2b83828ca33dd137d366ec6 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.14e-06 | 192 | 62 | 5 | e3be395a995dc8c0ebdae754057cfa59a270cae0 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.50e-06 | 194 | 62 | 5 | 40c91ed945bd5990a0dbf2090d37a660b19aaab2 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.89e-06 | 196 | 62 | 5 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-tDC|Leuk-UTI / Disease, condition lineage and cell class | 8.49e-06 | 199 | 62 | 5 | a2f154b15087803958a656d2a41b6d83fd37b32f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-05 | 118 | 62 | 4 | 7e6cb77fa9154f2da985c455bb6a24d6029cc8d6 | |
| ToppCell | TCGA-Skin|World / Sample_Type by Project: Shred V9 | 4.35e-05 | 140 | 62 | 4 | 57d9979bfdcb695869690bf62fa80759ad06eb6c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.99e-05 | 145 | 62 | 4 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.14e-05 | 159 | 62 | 4 | a5fee9e7ee00c20a4ba30b0dfaf1189fb109a1af | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-05 | 160 | 62 | 4 | 6bafbe2b4b98bc088406a516d079093f89d9c344 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.05e-05 | 164 | 62 | 4 | 662f74ad2656c0af158dbf9eb81d5bf70f54e529 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-05 | 164 | 62 | 4 | 0853e75b60b2a78257b660910c3ee15b09c5f5b0 | |
| ToppCell | facs-Heart-RV-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.44e-05 | 166 | 62 | 4 | 16d42eda958b2a6f9d598e9b4b967505dee426ef | |
| ToppCell | facs-Heart-RV-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.44e-05 | 166 | 62 | 4 | 08d7db4ff1c9c9cea3a36a87b8690838e79d4e0e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.64e-05 | 167 | 62 | 4 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.04e-05 | 169 | 62 | 4 | 0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.25e-05 | 170 | 62 | 4 | b49f7c8a27078de2137ed04f74cfee30729cfa5e | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 9.90e-05 | 173 | 62 | 4 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 62 | 4 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 62 | 4 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | 390C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 176 | 62 | 4 | aab9603b7943b7f7243eb6190ebba998566196f3 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-04 | 176 | 62 | 4 | dde46f06f6fc3f7ba83be91a0ee6231790955e3e | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 181 | 62 | 4 | 923b369b1404103f124fcbffa866de26f9d68d33 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 181 | 62 | 4 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 181 | 62 | 4 | 7fd96238673c9596562c43e7c5ddbab7d0e6c0c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 181 | 62 | 4 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | (0)_Normal/No_Treatment|World / Stress and Cell class | 1.18e-04 | 181 | 62 | 4 | 4077282c45a37403f47e8d1b9ac102e6b1ba2cf9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 181 | 62 | 4 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | 11.5-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 1.18e-04 | 181 | 62 | 4 | 193ee02f547a218b2fc13e1174ea4cff4f8a3450 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.20e-04 | 182 | 62 | 4 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | Control-Myeloid-MoAM3,_VCAN|Myeloid / Condition, Lineage and Cell class | 1.31e-04 | 186 | 62 | 4 | 0bf16ac48931b62bb3c33d63ff4279654148e293 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 186 | 62 | 4 | 0859737021747518731aa67fe181d4ca4fdc0721 | |
| ToppCell | (0)_Myeloid-(011)_pDC|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 1.36e-04 | 188 | 62 | 4 | a81b5d840490d6a636fe168f8cff2c4984369f09 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 189 | 62 | 4 | a010f3e4da6e9bb23b0b9a7f82ad5cee4e607ecd | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-04 | 189 | 62 | 4 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.39e-04 | 189 | 62 | 4 | cce6602ad68c177985a5e43cfb2776d615cfbca0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 190 | 62 | 4 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.42e-04 | 190 | 62 | 4 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-04 | 190 | 62 | 4 | 6514f00d222eef08c282face7f177259bca62f0e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 193 | 62 | 4 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 193 | 62 | 4 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | Nasal_Brush-Immune|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.54e-04 | 194 | 62 | 4 | 3135bc4a8112c5dee108e3b8e775f508b65191f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-04 | 194 | 62 | 4 | b191851b2287afc8c47320f5488fd22e2a454aa6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-04 | 195 | 62 | 4 | a2fe352682f548001ca2ee056e7a54af10134453 | |
| ToppCell | (1)_Dll4_loss-of-function|World / Stress and Cell class | 1.57e-04 | 195 | 62 | 4 | def4b2350e08a36ffddca71ea80ef611f2d437d9 | |
| ToppCell | (1)_Dll4_loss-of-function-(0)_LMPP_(LSK_cells)|World / Stress and Cell class | 1.57e-04 | 195 | 62 | 4 | f11cf4b6855a26ff6ea572eebaad2aad6bb2434b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 195 | 62 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-04 | 195 | 62 | 4 | f664fe18856065baaa2837fc82ea946e45f6fcc3 | |
| ToppCell | tumor_Lung-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.57e-04 | 195 | 62 | 4 | 3133591a289c06396cf4705d6a861369e145ac54 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 195 | 62 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Myelocyte-like|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.60e-04 | 196 | 62 | 4 | 4b88c96b737a747422674ad99c073b28e6febc7c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.60e-04 | 196 | 62 | 4 | 7dff78ff7b2b333680de1c9ca78190770574d796 | |
| ToppCell | myeloid-CD14+_Monocyte|World / Lineage and Cell class | 1.60e-04 | 196 | 62 | 4 | b70f9402a1707671c0dd44226fa2adfc4bde8283 | |
| ToppCell | myeloid|World / Lineage and Cell class | 1.60e-04 | 196 | 62 | 4 | c76af19827917b9f64ed9fff449f34d04e080a2a | |
| ToppCell | URO-Myeloid-CD14_Mono|URO / Disease, Lineage and Cell Type | 1.63e-04 | 197 | 62 | 4 | 45c16125fa32e50304fdd45a7cb457488bd50ee3 | |
| ToppCell | normal-na-Myeloid-classical_monocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-04 | 197 | 62 | 4 | dc53d1c0d226ca22291a489c38e08a7ccdc3aeeb | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.63e-04 | 197 | 62 | 4 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.63e-04 | 197 | 62 | 4 | e5a1e846bbfec234cb50c87c1f24beb43fce6856 | |
| ToppCell | normal-na-Myeloid-classical_monocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-04 | 197 | 62 | 4 | b98ceb82fe2126bbeb2df87a7243be0f2c0ccfa8 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.63e-04 | 197 | 62 | 4 | eecb693367510da20a6b1e9355e68785a1e3b85c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-04 | 198 | 62 | 4 | 5cd5cc67d7bb294582b5e9115cbddfd88aeb5220 | |
| ToppCell | normal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.66e-04 | 198 | 62 | 4 | 58aa5041077fe17ca01c5e6da077d8008d5123ab | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-04 | 198 | 62 | 4 | 311d3ef860d0d883130326fd4601ee9ad89029ff | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.66e-04 | 198 | 62 | 4 | 0af55f2b859e4626e23e2733bf9ae2ace4547079 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.66e-04 | 198 | 62 | 4 | dc59442e6a5127d3071a036c206732a21e456a17 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | 6fd984da5d2c419aeb34c8cbd8a00440e2f820a5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-04 | 198 | 62 | 4 | fa06b60e7ec58754bb622fd439613d63afd2205f | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic-monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-04 | 198 | 62 | 4 | eae8c29d68cc94bfbd15e487ad855639c2a4fcc9 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-04 | 198 | 62 | 4 | 2f94fb4a1719d5adddb4fd3dfaf099ee2b642011 | |
| ToppCell | ICU-NoSEP-Myeloid-CD14_Mono|ICU-NoSEP / Disease, Lineage and Cell Type | 1.66e-04 | 198 | 62 | 4 | c7880cc998f9d8473367ea00b77d930776392ced | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 1.66e-04 | 198 | 62 | 4 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell-Mast_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-04 | 198 | 62 | 4 | f75800b4f3cf0d493226db8db7c949caade0ff90 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.66e-04 | 198 | 62 | 4 | df546a9afc0e15398f33c1b511c7281771f9aea0 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Mast_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.66e-04 | 198 | 62 | 4 | 45089e0adf2c00f4b0bccd701f4daebf25858006 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.66e-04 | 198 | 62 | 4 | 2cfdcbf33854f314c41ea0f01c31bc27b66c2f91 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-04 | 198 | 62 | 4 | c65103828a4755fcf3c0776c60d8ada1f0ad5278 | |
| ToppCell | normal-na-Myeloid|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.66e-04 | 198 | 62 | 4 | fd8ab3de94c3dc551f28668317109656fc58e463 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-promonocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-04 | 198 | 62 | 4 | ff634a17195d06a8614ed1c6564937d10ca5c00d | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell-Mast_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.66e-04 | 198 | 62 | 4 | 4163220f4ccb825a8399298cfac8411eb2acc9a2 | |
| ToppCell | IIF-Myeloid-CD14_Mono|IIF / Disease, Lineage and Cell Type | 1.69e-04 | 199 | 62 | 4 | accfb3d8ad3f03f9302f2056ca16c1be6231a351 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, condition lineage and cell class | 1.69e-04 | 199 | 62 | 4 | a2be40d367338d32348a6906c8475aa3b544a0f7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-04 | 199 | 62 | 4 | 87956fcb39c2e3e99622ff05f99267d7621a78fc | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-04 | 199 | 62 | 4 | 126a0ebd40e55c0dfb5e7c7dd8fdd733da6aa323 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 199 | 62 | 4 | 15db14eff63d5edeced0738542d5fb739225511b | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 199 | 62 | 4 | 772b3f60b83e29b958e1e70dadfd9f058ed4cb7c | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-04 | 200 | 62 | 4 | 2bc7f462a551292de2501028164573935232f899 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-TRAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.73e-04 | 200 | 62 | 4 | ecd2b9a7d464792b77381d0a0bc7030e77ad3581 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-TRAM-TRAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.73e-04 | 200 | 62 | 4 | 196dd7a90f6f334496997af0375e7a2c86f9a197 | |
| ToppCell | Sepsis-URO-Myeloid-CD14+_Monocyte|URO / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | 209976dbbfc1edbeb3ea128cd0453ec9572f54cb | |
| ToppCell | MS-IIF-Myeloid-CD14+_Monocyte|IIF / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | 50d874971dabd3a3b26cc859d1977ffd01fad172 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-CD14+_Monocyte|ICU-SEP / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | 92c30e78c0e952bf4790f268d1a5facf3891682d | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-TRAM-TRAM-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-04 | 200 | 62 | 4 | 18f1415cfc718beffd91fb9f643cced2eefbca8d | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-TRAM-TRAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.73e-04 | 200 | 62 | 4 | b303553aca8fc021f932b52e88e9ef270d5a4f03 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-TRAM-TRAM-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-04 | 200 | 62 | 4 | ec39df7fb4454af629a4a4f6755bd02c9581a2ca | |
| Disease | QT interval, response to tricyclic antidepressant | 9.83e-05 | 8 | 56 | 2 | EFO_0004682, EFO_0007916 | |
| Disease | Colorectal Carcinoma | 3.53e-04 | 702 | 56 | 7 | C0009402 | |
| Disease | phosphatidylcholine 38:6 measurement | 4.17e-04 | 16 | 56 | 2 | EFO_0010388 | |
| Disease | triacylglycerol 58:9 measurement | 7.98e-04 | 22 | 56 | 2 | EFO_0010443 | |
| Disease | triacylglycerol 58:8 measurement | 2.02e-03 | 35 | 56 | 2 | EFO_0010442 | |
| Disease | Breast adenocarcinoma | 2.77e-03 | 41 | 56 | 2 | C0858252 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.77e-03 | 41 | 56 | 2 | C0496956 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLLYCRFLDNKLLLS | 501 | Q4AC99 | |
| LALILPLLFYLRKRN | 2236 | Q6UVK1 | |
| FLAILRLSLNYLIAR | 256 | Q6IC98 | |
| LDILYRRLLLTKLFI | 6 | Q0P651 | |
| LLALALGLLVYRKRR | 596 | Q9NPY3 | |
| LLLKRRSSFYIVNLL | 231 | Q9UGM1 | |
| LFRLIKRLDLSYNRI | 66 | Q86SJ2 | |
| LLAILLFFAVKYLLR | 641 | Q99467 | |
| IIALRHLRNLKYLLL | 171 | Q99766 | |
| RKLLRNLDFYVLPVL | 136 | Q8IVL8 | |
| GRDITRYLIKLLLLR | 186 | P61160 | |
| QREEYLLLRLFKTAL | 1016 | P46940 | |
| LLLLLVLLLAAYFFR | 56 | P23469 | |
| LLKLRQRVLFLLDGY | 236 | Q9NPP4 | |
| LSFIRLLLNYRKSSR | 1936 | Q8N201 | |
| SALRLKQRLVILERY | 136 | O95714 | |
| LDLLLRFQRLLISKL | 1051 | O95714 | |
| LLRSLDYVKRTLRNL | 126 | Q9NS86 | |
| KIRELQLRYSLRILI | 81 | Q5H9J7 | |
| INKLLLIDYAARRLV | 96 | P51805 | |
| RLQYSRDVRKLLLSI | 641 | P26006 | |
| EYEYLLALRLLNKLL | 2016 | O94915 | |
| LCRRLYKLHFQLLLL | 2831 | O94915 | |
| LLRLLRLLQKLERYS | 341 | Q9UQ05 | |
| DRLLLAFLLTLYLGL | 216 | Q8IXM6 | |
| YRELFDLALRGLQLL | 386 | Q96F07 | |
| DLSKLLAYIRLPLLA | 401 | Q96PQ7 | |
| ARLATRLLKLRYLIL | 91 | O60313 | |
| VYKLFSLQDLLLLVR | 731 | Q659A1 | |
| LLLQDSLLRLKDYRQ | 741 | Q9Y6J0 | |
| EALREEYLRLLKLLN | 481 | Q5VVM6 | |
| FLKELLFRINRLDLL | 61 | Q14790 | |
| LFRINRLDLLITYLN | 66 | Q14790 | |
| TRYLFALQLKRDLLE | 136 | O94887 | |
| ELLYLRRNKLRFLPE | 246 | Q9H9A6 | |
| RALKSLISFLILYAL | 231 | P59536 | |
| FLLFLTILKTLRYSR | 2056 | Q9NTG1 | |
| LRIERLLYAKRLFFD | 101 | Q9NYY8 | |
| YFLRLLHDKGLLLRL | 211 | Q9NTG7 | |
| LNLSIRRIIFYSLIK | 431 | Q8IYB8 | |
| LLLADYILFRQDLFR | 191 | Q9BUU2 | |
| ALLDQFYEKRRLLIV | 331 | P78539 | |
| RKKLRLYQFLLGLLT | 166 | Q01892 | |
| AAYSLLLFLLQIKDR | 431 | A4QPH2 | |
| YVLAVLLFLALLLQR | 356 | Q09428 | |
| DLLLTKRDSFLKRLY | 141 | Q9H553 | |
| LKGLLRSLLRFLSYS | 166 | O60543 | |
| ILFFILLYVLRLDRL | 56 | Q9UBR5 | |
| QRILKYPLLLRELFA | 1191 | Q13009 | |
| ILNLLYKLLAALIRG | 516 | Q15413 | |
| LLLYEARSLRLQKQF | 316 | Q12788 | |
| YDKIRVLLLYILLRN | 401 | Q15833 | |
| LVLRKARSLLYQFRL | 681 | Q8TBP0 | |
| LRVLAQKLLELLFDY | 86 | Q6P2H8 | |
| ILRDLLRFLLIYLVF | 531 | Q9Y5S1 | |
| LFVLLAFLQYRRLRK | 486 | P40126 | |
| LAILLALYLLRRDQR | 231 | P43489 | |
| LQLLRLFKLKERYRN | 541 | Q9ULQ1 | |
| LLRLAYLADIFTKLN | 471 | Q49AG3 | |
| LERLQEILRKFLYLE | 96 | Q8N720 | |
| RYKRRLNLDIILSLF | 456 | Q9UIE0 | |
| YKRRLNLDILLSLFL | 521 | Q12901 | |
| LENYLRKELLLLDLG | 51 | Q2TAA8 | |
| LRLLRLLQKLDRYSQ | 336 | Q96L42 | |
| KALHFYLIRALQLLR | 131 | Q96L15 |